Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP12 | P39900 | 11/20 | 0.68 |
| ▸ | MMP13 | P45452 | 10/20 | 0.68 |
| ▸ | MMP2 | P08253 | 1/20 | 0.68 |
| ▸ | MMP9 | P14780 | 1/20 | 0.68 |
| ▸ | MMP14 | P50281 | 1/20 | 0.68 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.49 |
| ▸ | PTGFR | P43088 | 1/20 | 0.49 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | DPP4 | P27487 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1139516 | 1.00 | MMP12 (0.68) | MMP12MMP13MMP2MMP9MMP14 | |
| SCHEMBL5613537 | 0.95 | MMP12 (0.77) | MMP12MMP13MMP2MMP9MMP14 | |
| SCHEMBL4552726 | 0.90 | MMP12 (0.55) | MMP12MMP13MMP2MMP9MMP14 | |
| SCHEMBL4745347 | 0.83 | MMP12 (0.80) | MMP12MMP13MMP2MMP9MMP14 | |
| SCHEMBL8333817 | 0.83 | MMP12 (0.80) | MMP12MMP13MMP2MMP9MMP14 | |
| SCHEMBL687094 | 0.83 | MMP12 (0.80) | MMP12MMP13MMP2MMP9MMP14 | |
| SCHEMBL3205639 | 0.82 | MMP12 (0.69) | MMP12MMP13MMP2MMP9MMP14 | |
| SCHEMBL5613511 | 0.82 | MMP12 (0.68) | MMP12MMP13MMP2MMP9MMP14 | |
| SCHEMBL1139059 | 0.82 | MMP12 (0.68) | MMP12MMP13MMP2MMP9MMP14 | |
| SCHEMBL6460810 | 0.82 | MMP12 (0.68) | MMP12MMP13MMP2MMP9MMP14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7632618-B2 | Polyhydroxyalkanoate-containing structure and manufacturing method thereof | CANON KABUSHIKI KAISHA (JP) | 2009-12-15 | — | — | US | disclosed |
| US-20090061498-A1 | POLYHYDROXYALKANOATE-CONTAINING STRUCTURE AND MANUFACTURING METHOD THEREOF | CANON KABUSHIKI KAISHA (JP) | 2009-03-05 | — | — | US | disclosed |
| EP-1254930-B1 | Particles for electrophoresis, a production method thereof and a display using the particles | CANON KK (JP) | 2008-06-18 | — | — | EP | disclosed |
| CN-100393881-C | Polyhydroxyalkanoate-containing structure and method for producing the same | CANON KK (JP) | 2008-06-11 | — | — | CN | disclosed |
| EP-1275728-B1 | Polyhydroxyalkanoate-containing structure and manufacturing method thereof | CANON KK (JP) | 2008-06-04 | — | — | EP | disclosed |
| US-7186459-B2 | Liposome coated with polyhydroxyalkanoate and production method thereof | CANON KABUSHIKI KAISHA (JP) | 2007-03-06 | — | — | US | disclosed |
| CN-1278675-C | Granular material comprising polyhydroxyalkanoate and method for producing the same | CANON KK (JP) | 2006-10-11 | — | — | CN | disclosed |
| EP-1256606-B1 | Pigment containing ink and production method thereof | CANON KK (JP) | 2006-03-08 | — | — | EP | disclosed |
| US-6951745-B2 | Synthesizing on base material polyhydroxyalkanoate using 3-hydroxyacyl coenzyme A to become substrate of synthase and coating base surface with polyhydroxyalkanoate where synthase contains sequence which binds to base | CANON KABUSHIKI KAISHA (JP) | 2005-10-04 | — | — | US | disclosed |
| US-20050208635-A1 | Polyhydroxyalkanoate-containing structure and manufacturing method thereof | CANON KABUSHIKI KAISHA (JP) | 2005-09-22 | — | — | US | disclosed |
| EP-1277464-B1 | Liposome coated with polyhydroxyalkanoate and production method thereof | CANON KK (JP) | 2004-10-06 | — | — | EP | disclosed |
| CN-1490357-A | Polyhydroxyalkanoate-containing structure and method for producing the same | ������������ʽ���� | 2004-04-21 | — | — | CN | disclosed |
| US-20030224494-A1 | Polyhydroxyalkanoate-containing structure and manufacturing method thereof | CANON KABUSHIKI KAISHA (JP) | 2003-12-04 | — | — | US | disclosed |
| US-20030206330-A1 | Particles for electrophoresis, a production method thereof and a display using the articles | CANON KABUSHIKI KAISHA (JP) | 2003-11-06 | — | — | US | disclosed |
| US-20030203987-A1 | Pigment containing ink and production method thereof | CANON KABUSHIKI KAISHA (JP) | 2003-10-30 | — | — | US | disclosed |
| CN-1431041-A | Granular material comprising polyhydroxyalkanoate and method for producing the same | CANON KK (JP) | 2003-07-23 | — | — | CN | disclosed |
| US-20030113368-A1 | Liposome coated with polyhydroxyalkanoate and production method thereof | CANON KABUSHIKI KAISHA (JP) | 2003-06-19 | — | — | US | disclosed |
| EP-1275728-A1 | Polyhydroxyalkanoate-containing structure and manufacturing method thereof | CANON KABUSHIKI KAISHA (JP) | 2003-01-15 | — | — | EP | disclosed |
| EP-1256606-A2 | Pigment containing ink and production method thereof | CANON KABUSHIKI KAISHA (JP) | 2002-11-13 | — | — | EP | disclosed |
| EP-1254930-A2 | Particles for electrophoresis, a production method thereof and a display using the particles | CANON KABUSHIKI KAISHA (JP) | 2002-11-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030113368-A1 | Liposome coated with polyhydroxyalkanoate and production method thereof | LIPA, ABHD16A, LIPE | MMP12 1924/4885MMP13 1623/4885MMP2 630/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.